Polyethylene Glycol-3350 And Electrolytes With Flavor Pack
PrescriptionNoms de marque : GaviLyte - C TM
About This Medication
DESCRIPTION GaviLyte- C with flavor pack is a white, colon lavage preparation provided as water-soluble components for solution. In solution this preparation with lemon flavor pack added delivers the following, in grams per liter. Polyethylene glycol 3350 240.00 Sodium chloride 5.84 Potassium chloride 6.72 Sodium bicarbonate 2.98 Sodium sulfate 22.72 Flavor ingredients 0.500 When dissolved in sufficient water to make 4 liters, the final solution contains 125 mEq/L sodium, 10 mEq/L potassium, 20 mEq/L bicarbonate, 80 mEq/L sulfate, 35 mEq/L chloride and 18 mEq/L polyethylene glycol 3350. The reconstituted solution is an isosmotic solution, for oral administration, having mild salty taste. This preparation can be used without the lemon flavor pack and is administered orally or via nasogastric tube. Each lemon flavor pack (2 g) contains natural lemon flavor powder, saccharin sodium, maltodextrin.
Principes Actifs
| Ingrédient | Dosage |
|---|---|
| Polyethylene Glycol 3350 | - |
| Potassium Chloride | - |
| Sodium Bicarbonate | - |
| Sodium Chloride | - |
| Sodium Sulfate Anhydrous | - |
Indications et Utilisation
Posologie et Administration
Side Effects Overview
Mises en Garde et Précautions
WARNINGS Flavor pack is for use only in combination with the contents of the accompanying 4 liter container. No other additional ingredients (e.g., flavorings) should be added to the solution. GaviLyte- C with flavor pack should be used with caution in patients with severe ulcerative colitis.
Contre-indications
CONTRAINDICATIONS GaviLyte- C with flavor pack is contraindicated in patients known to be hypersensitive to any of the components. GaviLyte- C with flavor pack is contraindicated in patients with ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or toxic megacolon.
Frequently Asked Questions
INDICATIONS AND USAGE GaviLyte- C with flavor pack is indicated for bowel cleansing prior to colonoscopy or barium enema X-ray examination.
DOSAGE AND ADMINISTRATION GaviLyte- C with flavor pack can be administered orally or by nasogastric tube. Patients should fast at least 3 hours prior to administration. A one hour waiting period after the appearance of clear liquid stool should be allowed prior to examination to complete bowel evacuation. No foods except clear liquids should be permitted prior to examination after GaviLyte- C with flavor pack administration. ORAL: The recommended adult oral dose is 240 mL (8 fl. oz.) every 10 …
WARNINGS Flavor pack is for use only in combination with the contents of the accompanying 4 liter container. No other additional ingredients (e.g., flavorings) should be added to the solution. GaviLyte- C with flavor pack should be used with caution in patients with severe ulcerative colitis.
CONTRAINDICATIONS GaviLyte- C with flavor pack is contraindicated in patients known to be hypersensitive to any of the components. GaviLyte- C with flavor pack is contraindicated in patients with ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or toxic megacolon.
Polyethylene Glycol-3350 And Electrolytes With Flavor Pack is a prescription medication. You will need a valid prescription from a licensed healthcare provider.
Similar Liquid/Solution Products
Browse all Liquid/Solution products →References & Data Sources
- • DailyMed — Polyethylene Glycol-3350 And Electrolytes With Flavor Pack drug label (National Library of Medicine)
- • openFDA — Polyethylene Glycol-3350 And Electrolytes With Flavor Pack label data (U.S. Food & Drug Administration)
- • RxNorm — RXCUI 966914 (NLM Normalized Drug Names)
- • NDC Directory — Polyethylene Glycol-3350 And Electrolytes With Flavor Pack (FDA National Drug Code)
Avertissement Médical
Les informations sur cette page sont destinées à des fins éducatives uniquement et ne doivent pas être utilisées en remplacement d'un avis médical professionnel, d'un diagnostic ou d'un traitement.
Consultez toujours votre médecin ou tout autre professionnel de santé qualifié pour toute question relative à une condition médicale ou à un médicament.
Sources des données : DailyMed (NLM), openFDA, MFDS